Blog
Federal Circuit Clarifies When Inherency Makes Patent Claims Obvious in Cytiva v. JSR
December 4, 2024
Cytiva BioProcess R&D AB v. JSR Corp Authored by: Jeremy J. Gustrowsky In a significant decision for biotechnology patents, the Federal Circuit recently addressed the concept of inherency in obviousness determinations in Cytiva BioProcess R&D AB v. JSR Corp. The…
Read MoreFacebook Defeats Patent Claims Over News Feed and Timeline Features
December 4, 2024
Mirror Worlds Techs., LLC v. Meta Platforms, Inc Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has closed the book on a long-running patent dispute between Mirror Worlds Technologies, LLC and Meta Platforms, Inc. (formerly Facebook, Inc.), with…
Read MoreWhen Is a “Single Action” Not Enough? Federal Circuit Clarifies Doctrine of Equivalents Proof Requirements
October 24, 2024
Nexstep, Inc. v. Comcast Cable Commc’ns, LLC Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision has clarified the high bar for proving patent infringement under the doctrine of equivalents, especially when the technology at issue seems simple. The…
Read MoreForeign Antisuit Injunctions in SEP Disputes: Federal Circuit Clarifies When U.S. Courts Can Step In
October 24, 2024
Telefonaktiebolaget LM Ericsson v. Lenovo (United States), Inc Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision sheds light on when U.S. courts can stop companies from enforcing foreign patent injunctions in global disputes over standard-essential patents (SEPs –…
Read MoreWhen Is a “Group” Not a Group? Federal Circuit Sends Patent Dispute Back for More Claim Construction
October 18, 2024
UTTO Inc. v. Metrotech Corp Authored by: Jeremy J. Gustrowsky A recent decision highlights how the meaning of just one word in a patent claim can make or break an infringement lawsuit. UTTO Inc. owns U.S. Patent No. 9,086,441, which…
Read MoreFederal Circuit Revives AlexSam’s Patent Infringement Claims Against Aetna Over Multifunction Card Technology
October 8, 2024
AlexSam, Inc. v. Aetna, Inc Authored by: Jeremy J. Gustrowsky In a significant decision for patent holders, the Federal Circuit has breathed new life into AlexSam, Inc.’s lawsuit against Aetna, Inc., overturning a district court’s dismissal of claims involving multifunction…
Read MoreFederal Circuit Clarifies Double Patenting and Written Description in Allergan v. MSN Labs
October 8, 2024
Allergan USA, Inc. v. MSN Labs. Priv. Ltd Authored by: Jeremy J. Gustrowsky In a significant decision for pharmaceutical patent holders, the Federal Circuit reversed a district court’s ruling that had invalidated several Allergan patents related to the drug eluxadoline,…
Read MoreFalse “Patented” Claims Can Violate the Lanham Act, Says Federal Circuit in Crocs v. Effervescent
October 3, 2024
Crocs, Inc. v. Effervescent, Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit clarified that companies can be held liable under the Lanham Act for falsely advertising their products as “patented” when those claims mislead consumers…
Read MorePatent Damages and Willfulness Standards Tightened in Food Machinery Patent Dispute
October 2, 2024
Provisur Techs., Inc. v. Weber, Inc Authored by: Jeremy J. Gustrowsky A recent appellate decision has clarified several important issues in patent law, particularly around proving infringement, willful infringement, and calculating damages. The case involved Provisur Technologies, Inc., which owns…
Read MoreFederal Circuit Admonishes District Court for Deciding Patent Eligibility Issue That Neither Party Raised
September 18, 2024
Astellas Pharma, Inc. v. Sandoz Inc Authored by: Jeremy J. Gustrowsky In a recent decision, the Federal Circuit vacated a district court ruling that had invalidated key claims of Astellas Pharma’s patent for its overactive bladder drug, Myrbetriq® (U.S. Patent…
Read MoreArmy’s $245 Million Special Forces Training Contract Survives Bid Protest After Federal Circuit Review
September 16, 2024
Oak Grove Techs., LLC v. United States Authored by: Jeremy J. Gustrowsky A recent Federal Circuit decision highlights the complex rules that govern government contract awards, especially when multiple companies challenge the process. The dispute centered on a $245 million…
Read MorePatent Claims Don’t Have to Be Mutually Exclusive, Says Appeals Court in Catheter Patent Dispute
September 16, 2024
Vascular Sols. LLC v. Medtronic, Inc Authored by: Jeremy J. Gustrowsky A recent decision from the Federal Circuit offers important guidance for patent owners and litigants about how patent claims can be drafted and interpreted—especially when it comes to claims…
Read More